Home›Stock Screener›Bal Pharma›P/E Ratio

Bal Pharma P/E Ratio

Current P/E Ratio
23.21
Moderate Valuation
High - Growth expectations or overvalued

Bal Pharma P/E ratio. Bal Pharma (BALPHARMA) P/E ratio is 23.21 (Moderate), EPS (TTM) ₹3.95, current price ₹105.74 on NSE vs historical average P/E of 32.31 (40.0th percentile) — High - Growth expectations or overvalued. For live price, revenue and the complete fundamental profile, see Bal Pharma share price chart.

Current Valuation Metrics

P/E Ratio 23.21
Current Price ₹105.74
EPS (TTM) ₹3.95
Exchange NSE

Valuation Signal

Signal Overvalued
Historical Avg 32.31
Historical Range 11.47 - 64.14
Percentile 40.0%

Sector Context

Sector Average 56.36
Sector Median 32.5
Sector Rank #11 of 199
Sector Percentile 5.5%

Earnings Breakdown (TTM)

TTM EPS ₹6.82
Mar 2026 ₹2.26
Jun 2026 ₹0.71

BALPHARMA P/E Ratio — Valuation Signal & Historical Context

Bal Pharma P/E 23.21 vs historical average 32.31, range 11.47–64.14 — signal: Overvalued. Examine Bal Pharma quarterly earnings for recent quarterly revenue, profit and EPS trends.

  • Current PE is 28.2% below historical average
  • Trading at discount to sector average PE of 56.36

Bal Pharma P/E Ratio Historical Trend

BALPHARMA annual price-to-earnings ratio — 5 years, EPS and year-end price. Current P/E 23.21 vs historical average 32.31. Also explore BALPHARMA stock price history to track price trends across different timeframes.

BALPHARMA Historical P/E Ratio — EPS, Year-End Price & Valuation

Bal Pharma annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2025 24.67 5.1 ₹125.80 NSE Moderate
2024 20.64 4.87 ₹100.50 NSE Moderate
2023 40.64 2.25 ₹91.45 NSE High
2022 64.14 1.98 ₹127.00 NSE High
2021 11.47 4.9 ₹56.20 NSE Low

BALPHARMA vs Healthcare Peers — P/E Ratio Comparison

Bal Pharma P/E 23.21 vs Healthcare average 56.36, median 32.5 — range 2.04–740.29.

Sector Average
56.36
Sector Median
32.5
Lowest P/E
2.04
Highest P/E
740.29
Companies
199
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Sunrest Lifescience SUNREST 2.04 ₹65 Low
Murae Organisor MURAE 2.86 ₹41 Low
Phaarmasia PHRMASI 3.41 ₹63 Low
Sun Pharma Advanced Rese… SPARC 3.98 ₹6,206 Low
Dipna Pharmachem DPL 4.57 ₹12 Low
JFL Life Sciences JFLLIFE 4.88 ₹66 Low
GKB Ophthalmics GKB 5.88 ₹32 Low
Kabra Drugs KABRADG 6.09 ₹44 Low
Royal Sense ROYAL 6.58 ₹47 Low
Colinz Laboratories COLINZ 6.62 ₹18 Low